Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of 4-MUST in Healthy Volunteers
NCT06315387Phase 1Recruiting
- Sponsor
- Valenta Pharm
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 4-MUST in cholecystitis (3 arms), sponsored by Valenta Pharm. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 3 more. Started Dec 2023; status: recruiting.
02
Drugs
4-MUST
03
Conditions
cholecystitis
Beyond the preview
Go deeper on NCT06315387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315387.